Mohamed Fayed

Mohamed Fayed is an Associate Clinical Professor of Pulmonology at the University of California, San Francisco (UCSF), specializing in critical care medicine and pulmonary diseases. Board-certified in Internal Medicine, Pulmonary Disease, and Critical Care, he completed his residency at Wright State University and fellowship at UCSF Fresno. His clinical research centers on pulmonary infections, ECMO applications, and lung cancer diagnostics.

Education:

• MD, University of Cairo Faculty of Medicine (2007)
• Residency in Internal Medicine, Wright State University
• Fellowship in Pulmonary Critical Care, UCSF Fresno

Dr. Fayed's research examines complex respiratory failures, COVID-19 therapeutics, and fungal pulmonary infections. Recent publications include randomized trials on antiviral treatments and case studies on ECMO applications in obstetric critical care, reflecting his focus on translational critical care.

His 2020-2024 publications demonstrate consistent engagement with pandemic response, including landmark trials on hydroxychloroquine and remdesivir, alongside innovations in ECMO protocols for COVID-19 and metformin toxicity. Clinical case studies advance rare disease diagnostics and autoimmune pulmonary complications.

Awards:

• Malcom Block Award for Teaching Excellence (2012-2013)
• Outstanding Chief Resident (2012-2013)
• Best Teaching Resident (2011-2012)

As a clinician-educator, he contributes to UCSF's critical care training programs and participates in NIH-sponsored trials on respiratory failure management. His multilingual fluency (English/Arabic) supports diverse patient care initiatives.